L-701,324 manufacturers
- L-701324
-
- $34.00 / 5mg
-
2024-11-19
- CAS:142326-59-8
- Min. Order:
- Purity: 98.63%
- Supply Ability: 10g
- L-701,324
-
- $7.00 / 1KG
-
2020-01-14
- CAS:142326-59-8
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 1000kg
|
| | L-701,324 Basic information |
| Product Name: | L-701,324 | | Synonyms: | 7-CHLORO-4-HYDROXY-3-(3-PHENOXY)PHENYL-2(1H)-QUINOLINONE;7-CHLORO-4-HYDROXY-3-(3-PHENOXY )PHENYLQUINOLIN-2[1H]-ONE;7-Chloro-4-hydroxy-3-(3-phenoxy)phenyl-2(H)-quinolinone;L-701,304;7-chloro-1-(4-hydroxy-3-phenoxyphenyl)quinolin-2(1H)-one;L-701;L-701,324;CS-2045 | | CAS: | 142326-59-8 | | MF: | C21H14ClNO3 | | MW: | 363.79 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 142326-59-8.mol |  |
| | L-701,324 Chemical Properties |
| Melting point | 308 °C | | Boiling point | 584.7±50.0 °C(Predicted) | | density | 1.389±0.06 g/cm3(Predicted) | | storage temp. | Sealed in dry,Room Temperature | | solubility | DMSO: soluble36.4mg/mL | | form | solid | | pka | 4.50±1.00(Predicted) | | color | White to off-white |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 3 |
| | L-701,324 Usage And Synthesis |
| Uses | L-701,324 is a potential anticonvulsant with high selectivity and affinity for the NMDA receptor glycine site. NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment. | | Definition | ChEBI: 7-chloro-4-hydroxy-3-(3-phenoxyphenyl)-1H-quinolin-2-one is a member of quinolines. | | Biological Activity | An orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor. | | storage | Store at RT |
| | L-701,324 Preparation Products And Raw materials |
|